RT Journal Article
SR Electronic
T1 Clinical Characteristics of Hospitalized Covid-19 Patients in New York City
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.19.20062117
DO 10.1101/2020.04.19.20062117
A1 Paranjpe, Ishan
A1 Russak, Adam J
A1 De Freitas, Jessica K
A1 Lala, Anuradha
A1 Miotto, Riccardo
A1 Vaid, Akhil
A1 Johnson, Kipp W.
A1 Danieletto, Matteo
A1 Golden, Eddye
A1 Meyer, Dara
A1 Singh, Manbir
A1 Somani, Sulaiman
A1 Manna, Sayan
A1 Nangia, Udit
A1 Kapoor, Arjun
A1 O’Hagan, Ross
A1 O’Reilly, Paul F
A1 Huckins, Laura M
A1 Glowe, Patricia
A1 Kia, Arash
A1 Timsina, Prem
A1 Freeman, Robert M
A1 Levin, Matthew A
A1 Jhang, Jeffrey
A1 Firpo, Adolfo
A1 Kovatch, Patricia
A1 Finkelstein, Joseph
A1 Aberg, Judith A
A1 Bagiella, Emilia
A1 Horowitz, Carol R
A1 Murphy, Barbara
A1 Fayad, Zahi A
A1 Narula, Jagat
A1 Nestler, Eric J
A1 Fuster, Valentin
A1 Cordon-Cardo, Carlos
A1 Charney, Dennis S
A1 Reich, David L
A1 Just, Allan C
A1 Bottinger, Erwin P
A1 Charney, Alexander W
A1 Glicksberg, Benjamin S
A1 Nadkarni, Girish N
A1 ,
YR 2020
UL http://medrxiv.org/content/early/2020/04/26/2020.04.19.20062117.abstract
AB Background The coronavirus 2019 (Covid-19) pandemic is a global public health crisis, with over 1.6 million cases and 95,000 deaths worldwide. Data are needed regarding the clinical course of hospitalized patients, particularly in the United States.Methods Demographic, clinical, and outcomes data for patients admitted to five Mount Sinai Health System hospitals with confirmed Covid-19 between February 27 and April 2, 2020 were identified through institutional electronic health records. We conducted a descriptive study of patients who had in-hospital mortality or were discharged alive.Results A total of 2,199 patients with Covid-19 were hospitalized during the study period. As of April 2nd, 1,121 (51%) patients remained hospitalized, and 1,078 (49%) completed their hospital course. Of the latter, the overall mortality was 29%, and 36% required intensive care. The median age was 65 years overall and 75 years in those who died. Pre-existing conditions were present in 65% of those who died and 46% of those discharged. In those who died, the admission median lymphocyte percentage was 11.7%, D-dimer was 2.4 ug/ml, C-reactive protein was 162 mg/L, and procalcitonin was 0.44 ng/mL. In those discharged, the admission median lymphocyte percentage was 16.6%, D-dimer was 0.93 ug/ml, C-reactive protein was 79 mg/L, and procalcitonin was 0.09 ng/mL.Conclusions This is the largest and most diverse case series of hospitalized patients with Covid-19 in the United States to date. Requirement of intensive care and mortality were high. Patients who died typically had pre-existing conditions and severe perturbations in inflammatory markers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was Supported by U54 TR001433-05, National Center for Advancing Translational Sciences, National Institutes of Health.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA